JP2018527030A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527030A5
JP2018527030A5 JP2018534009A JP2018534009A JP2018527030A5 JP 2018527030 A5 JP2018527030 A5 JP 2018527030A5 JP 2018534009 A JP2018534009 A JP 2018534009A JP 2018534009 A JP2018534009 A JP 2018534009A JP 2018527030 A5 JP2018527030 A5 JP 2018527030A5
Authority
JP
Japan
Prior art keywords
seq
rap
sequence
precursor protein
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018534009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527030A (ja
JP6976254B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/071947 external-priority patent/WO2017046314A2/en
Publication of JP2018527030A publication Critical patent/JP2018527030A/ja
Publication of JP2018527030A5 publication Critical patent/JP2018527030A5/ja
Application granted granted Critical
Publication of JP6976254B2 publication Critical patent/JP6976254B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018534009A 2015-09-18 2016-09-16 Ｃｄ−ｒａｐ前駆体タンパク質の使用による、ｃｄ−ｒａｐの製造方法における発現およびフォールディングの改善 Expired - Fee Related JP6976254B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP15306457.1 2015-09-18
EP15306457 2015-09-18
EP15306458 2015-09-18
EP15306458.9 2015-09-18
EP15306950 2015-12-07
EP15306950.5 2015-12-07
PCT/EP2016/071947 WO2017046314A2 (en) 2015-09-18 2016-09-16 Improvement of expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor protein

Publications (3)

Publication Number Publication Date
JP2018527030A JP2018527030A (ja) 2018-09-20
JP2018527030A5 true JP2018527030A5 (enExample) 2019-10-17
JP6976254B2 JP6976254B2 (ja) 2021-12-08

Family

ID=57223637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534009A Expired - Fee Related JP6976254B2 (ja) 2015-09-18 2016-09-16 Ｃｄ−ｒａｐ前駆体タンパク質の使用による、ｃｄ−ｒａｐの製造方法における発現およびフォールディングの改善

Country Status (8)

Country Link
US (2) US10660852B2 (enExample)
EP (1) EP3350204A2 (enExample)
JP (1) JP6976254B2 (enExample)
CN (1) CN108602866A (enExample)
AU (2) AU2016321884B2 (enExample)
CA (1) CA2998665A1 (enExample)
TW (1) TW201726712A (enExample)
WO (1) WO2017046314A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210219569A1 (en) * 2018-03-16 2021-07-22 Eco-Geo Bio-Technology Company Limited Use and composition of buffer formulation with multiple ph values and protein digestion enhancer
CN108410803B (zh) * 2018-03-28 2019-02-05 湖南源品细胞生物科技有限公司 一种诱导脂肪干细胞成软骨分化的培养方法和培养液
FR3092339B1 (fr) * 2019-02-05 2024-04-12 Michelin & Cie Cellule, notamment levure, resistante au phloroglucinol
CN113024675A (zh) * 2020-12-29 2021-06-25 山东第一医科大学(山东省医学科学院) 一种hb-nc4重组蛋白及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
WO2001002564A1 (fr) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
JP4579378B2 (ja) * 1999-06-30 2010-11-10 武田薬品工業株式会社 新規ポリペプチドおよびそのｄｎａ
EP1604693A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
ES2708851T3 (es) * 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
US20130095122A1 (en) * 2010-03-17 2013-04-18 Anja Katrin Bosserhoff Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
CA2792965A1 (en) * 2010-04-27 2011-11-03 Scil Technology Gmbh Stable aqueous mia/cd-rap formulations

Similar Documents

Publication Publication Date Title
JP2018527030A5 (enExample)
JP2018537087A5 (enExample)
MY169472A (en) Refolding of recombinant proteins
JP2009268467A5 (enExample)
JP2012532601A5 (enExample)
NZ705575A (en) Recombinant clostridium botulinum neurotoxins
NO20090451L (no) Fremgangsmate for fremstilling av konjugater av insulin-lignende vekst faktor-1 og poly(etylenglukol)
JP2015524403A5 (enExample)
WO2002070647A3 (en) Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
WO2011112856A3 (en) Novel protein peptide hydrogels
RU2016104651A (ru) Устойчивые к протеазам пептидные лиганды
DE502004011932D1 (de) Verfahren zur herstellung von 3-methylamino-1-(thien-2-yl)-propan-1-ol
JP2014504297A5 (enExample)
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
DE602007011616D1 (de) Verfahren zur herstellung von oligopeptiden
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
CN110036108A (zh) 一种细菌β-1,3-葡聚糖酶及其编码基因与应用
HK1250992A1 (zh) 表皮生长因子受体变体iii-间皮素融合物及其使用方法
DE60326449D1 (de) Chimere human papilloma virus 16 l1 proteine, welche ein l2 peptid enthalten, damit hergestellte virus-ähnliche partikel und methode zur herstellung der partikel
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids
MX2019002134A (es) Nuevo paramixovirus y sus usos.
JP2015510770A5 (enExample)
NZ706202A (en) Peptide antagonists of the vasopressin-2 receptor
WO2010013767A1 (ja) 新規なプロテアーゼおよびその利用